Study: More Patients Using Cannabinoids for Fibromyalgia Pain
Of 457 patients referred to a fibromyalgia clinic, 13 percent self-reported using cannabinoids, according to researcher Mary-Ann Fitzcharles of McGill University. A total of 80 percent were marijuana smokers, while 24 percent used prescription formulations and 3 percent used both, researchers reported in Arthritis Care & Research.
"The cannabinoid system has known modulatory effects on pain, inflammation, immune function and even joint damage," said Ms. Fitzcharles. "It is therefore reasonable to question whether the effects of cannabinoid agonists, either natural or synthetic, may have relevance to the management of patients with pain conditions such as [fibromyalgia]."
Related Articles on Pain Management:10 Pain Management Specialist Appointments
FDA Approves Lyrica for Neuropathic Pain Management
Lobbying Effort Aims to Tighten Control on Painkillers
© Copyright ASC COMMUNICATIONS 2012. Interested in LINKING to or REPRINTING this content? View our policies by clicking here.
To receive the latest hospital and health system business and legal news and analysis from Becker's Hospital Review, sign-up for the free Becker's Hospital Review E-weekly by clicking here.